China Dasheng Biotechnology Co
OTC:CDBT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/IC
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Valuation Scenarios
If EV/IC returns to its Industry Average (1), the stock would be worth $-0.07 (256% downside from current price).
| Scenario | EV/IC Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.6 | $0.04 |
0%
|
| Industry Average | 1 | $-0.07 |
-256%
|
| Country Average | 1.5 | $-0.1 |
-335%
|
Forward EV/IC
Today’s price vs future invested capital
Peer Comparison
| Market Cap | EV/IC | P/E | ||||
|---|---|---|---|---|---|---|
| US |
C
|
China Dasheng Biotechnology Co
OTC:CDBT
|
1.7m USD | -0.6 | 0.3 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
13.2T JPY | 3.1 | 27.8 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
79.7B USD | 3.9 | 31 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
73.5B USD | 3.7 | 35.4 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | 0.6 | 10.5 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
280.3B CNY | 1.6 | 21.3 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
25.7B CHF | 2.9 | 24 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 6.6 | 54.8 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.3T INR | 10.8 | 60.8 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
24.2B USD | 1.8 | 15.4 | |
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR | 1.6 | 17.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.9 |
| Median | 1.5 |
| 70th Percentile | 2.9 |
| Max | 566 432.7 |
Other Multiples
China Dasheng Biotechnology Co
Glance View
China Dasheng Biotechnology Co. engages in the development, manufacture and sale of bacteria based products, which are used as additives for livestock feed and crop cultivation. The company is headquartered in Scottsdale, Arizona and currently employs 689 full-time employees. The company went IPO on 2008-02-13. The firm is not engaged in any business and has not generated any revenue.
